We previously demonstrated, using a nerve-cooling technique, that the vagus nerves are not essential for the counterregulatory response to hypoglycemia caused by high levels of insulin. Because high insulin levels per se augment the central nervous system response to hypoglycemia, the question arises whether afferent nerve fibers traveling along the vagus nerves would play a role in the defense of hypoglycemia in the presence of a more moderate insulin level. To address this issue, we studied two groups of conscious 18-h-fasted dogs with cooling coils previously placed on both vagus nerves. Each study consisted of a 100-min equilibration period, a 40-min basal period, and a 150-min hypoglycemic period. Glucose was lowered using a glycogen phosphorylase inhibitor and a low dose of insulin infused into the portal vein (0.7 mU ⅐ kg ؊1 ⅐ min ؊1 ). The arterial plasma insulin level increased to 15 ؎ 2 U/ml and the plasma glucose level fell to a plateau of 57 ؎ 3 mg/dl in both groups. The vagal cooling coils were perfused with a 37°C (SHAM COOL; n ؍ 7) or a ؊20°C (COOL; n ؍ 7) ethanol solution for the last 90 min of the study to block parasympathetic afferent fibers. Vagal cooling caused a marked increase in the heart rate and blocked the hypoglycemia-induced increase in the arterial pancreatic polypeptide level. The average increments in glucagon (pg/ml), epinephrine (pg/ml), norepinephrine (pg/ ml), cortisol (g/dl), glucose production (mg ⅐ kg -1 ⅐ min -1 ), and glycerol (mol/l) in the SHAM COOL group were 53 ؎ 9, 625 ؎ 186, 131 ؎ 48, 4.63 ؎ 1.05, ؊0.79 ؎ 0.24, and 101 ؎ 18, respectively, and in the COOL group, the increments were 39 ؎ 7, 837 ؎ 235, 93 ؎ 39, 6.28 ؎ 1.03 (P < 0.05), ؊0.80 ؎ 0.20, and 73 ؎ 29, respectively. Based on these data, we conclude that, even in the absence of high insulin concentrations, afferent signaling via the vagus nerves is not required for a normal counterregulatory response to hypoglycemia. Diabetes 50: 558 -564, 2001 H ypoglycemia is a serious condition that can lead to death if the organism does not respond properly. The physiological response to hypoglycemia involves an increase in the plasma levels of a variety of counterregulatory hormones, including glucagon, cortisol, epinephrine, norepinephrine, and growth hormone. This hormonal response results in an increase in glucose production and a decrease in glucose utilization, thereby defending the organism against the hypoglycemia. Individuals with type 1 diabetes have a blunted counterregulatory response to hypoglycemia, making them more vulnerable to low blood glucose. It is of clinical importance, therefore, to understand which areas of the body are responsible for sensing a decrease in blood glucose. The site of hypoglycemic sensing is controversial. Until recently, the brain was generally accepted as the site of detection of hypoglycemia. In accordance with this, Borg et al.(1) demonstrated in rats that ablation of the ventromedial hypothalamus abolished the counterregulatory response to hypoglycemia. In the conscious dog, ...